These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The qualitative dynamics of angina pectoris and the effect of certain drugs as recorded with the high-frequency (acceleration) direct body ballistocardiograph. Winer NJ Bibl Cardiol; 1973; 0(31):181-8. PubMed ID: 4213474 [No Abstract] [Full Text] [Related]
8. Studies on the effect of dipyridamole and propranolol on coronary circulation in human subjects with and without coronary heart disease. Takezawa H; Kitamura H; Komada M; Tanimura H; Masui K Jpn Circ J; 1968 Nov; 32(11):1565-9. PubMed ID: 5756393 [No Abstract] [Full Text] [Related]
9. Cardiovascular pharmacology of propranolol in man. Wolfson S; Gorlin R Circulation; 1969 Oct; 40(4):501-11. PubMed ID: 5823547 [No Abstract] [Full Text] [Related]
10. Systemic and coronary hemodynamic effects of perhexiline. Rowe GG; Spring DA; Afonso S Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275 [No Abstract] [Full Text] [Related]
11. The effect of adrenaline, noradrenaline, and propranolol on myocardial blood flow and metabolic heat production in monkeys and baboons. Parratt JR Cardiovasc Res; 1969 Jul; 3(3):306-14. PubMed ID: 4980762 [No Abstract] [Full Text] [Related]
12. Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease. Lewis CM; Brink AJ Am J Cardiol; 1968 Jun; 21(6):846-59. PubMed ID: 5678218 [No Abstract] [Full Text] [Related]
13. Circulatory effects of propranolol in children with Fallot's tetralogy. Observations with isoproterenol infusion, exercise and crying. Shah PM; Kidd L Am J Cardiol; 1967 May; 19(5):653-7. PubMed ID: 6024709 [No Abstract] [Full Text] [Related]
14. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris. Hebb AR; Godwin TF; Gunn RW Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821 [No Abstract] [Full Text] [Related]
15. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina. Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953 [No Abstract] [Full Text] [Related]
16. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris. Pine M; Favrot L; Smith S; McDonald K; Chidsey CA Circulation; 1975 Nov; 52(5):886-93. PubMed ID: 1175271 [TBL] [Abstract][Full Text] [Related]
17. Effect of sympathetic stimulation and blockade in patients with angina pectoris. A clinical conference in cardiography from the University of Kentucky Medical Center, Lexington, Kentucky. Gettes LS; Yoshonis KF; Logic JR; Luria MH; Surawicz B Dis Chest; 1968 Nov; 54(5):450-6. PubMed ID: 5698590 [No Abstract] [Full Text] [Related]
18. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Aström H; Vallin H Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316 [No Abstract] [Full Text] [Related]